NASDAQ · CURX
Healthcare · Biotechnology
$5.31
Up+$0.55 (+11.55%)
Updated Oct 11, 2026, 10:53 AM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · CURX
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
CURX closed at $5.31 after 20 trading sessions, up 18.26% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $4.61 | $5.31 | $4.61 | $5.31 | 17.09K |
| Oct 8, 2026 | $4.75 | $4.90 | $4.51 | $4.76 | 14.42K |
| Oct 7, 2026 | $4.79 | $5.15 | $4.45 | $4.77 | 102.01K |
| Oct 6, 2026 | $5.09 | $5.29 | $4.875 | $4.99 | 42.32K |
| Oct 5, 2026 | $4.32 | $5.04 | $4.32 | $4.96 | 87.38K |
| Oct 2, 2026 | $4.70 | $5.099 | $4.59 | $4.72 | 2.71K |
| Oct 1, 2026 | $4.93 | $5.05 | $4.7501 | $4.97 | 7.99K |
| Sep 30, 2026 | $4.99 | $5.03 | $4.99 | $5.03 | 1.18K |
| Sep 29, 2026 | $5.08 | $5.08 | $4.97 | $4.97 | 1.05K |
| Sep 28, 2026 | $4.81 | $5.27 | $4.44 | $5.0349 | 20.58K |
| Sep 25, 2026 | $4.415 | $5.00 | $4.40 | $4.74 | 71.27K |
| Sep 24, 2026 | $4.45 | $4.50 | $4.3009 | $4.45 | 3.38K |
| Sep 23, 2026 | $4.44 | $4.475 | $4.4001 | $4.475 | 4.34K |
| Sep 22, 2026 | $4.80 | $4.88 | $4.40 | $4.58 | 24.14K |
| Sep 21, 2026 | $4.29 | $4.50 | $4.0501 | $4.37 | 16.4K |
| Sep 18, 2026 | $4.40 | $4.875 | $4.40 | $4.40 | 21.29K |
| Sep 17, 2026 | $4.11 | $4.60 | $4.11 | $4.60 | 13.8K |
| Sep 16, 2026 | $4.21 | $4.38 | $4.13 | $4.19 | 7.53K |
| Sep 15, 2026 | $4.56 | $4.69 | $4.251 | $4.29 | 6.21K |
| Sep 14, 2026 | $4.41 | $4.69 | $4.36 | $4.49 | 5.56K |
The latest Smart Investors Daily articles mentioning CURX.
Company
Market Activity
Research & News
CURX research
Company profile and research snapshot.
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
ChartMill · Feb 26, 2026
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.
ChartMill · Feb 26, 2026
Let's dive into the action on the US markets on Thursday. Here are the most active stocks that are driving the market today.
ChartMill · Feb 26, 2026
Unusual volume stocks in Thursday's session
ChartMill · Feb 26, 2026
Wondering how the US markets performed in the middle of the day on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CURX.
No results
No recent SID articles mention CURX.
